Insmed Inc. buy Guggenheim
Start price
08.09.25
/
50%
€125.00
Target price
08.09.26
€146.89
Performance (%)
-1.60%
Price
08:47
?
Summary
This prediction is currently active. With a performance of -1.60%, the BUY prediction for Insmed Inc. by Guggenheim is down slightly. This prediction currently runs until 08.09.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Insmed Inc. | 5.691% | 5.691% |
| iShares Core DAX® | -3.640% | -8.784% |
| iShares Nasdaq 100 | -2.986% | -1.710% |
| iShares Nikkei 225® | -3.000% | -9.097% |
| iShares S&P 500 | -2.389% | -2.781% |
Comments by Guggenheim for this prediction
In the thread Insmed Inc. diskutieren
Insmed (NASDAQ:INSM) had its price target raised by analysts at Guggenheim from $125.00 to $172.00. They now have a "buy" rating on the stock.
Ratings data for INSM provided by MarketBeat